Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04834973
Status:
TERMINATED
Last Update Posted:
2023-04-18
First Post:
2021-03-29
Brief Title:
A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma
Sponsor:
QBiotics Group Limited
Organization:
QBiotics Group Limited
Organization Data
Organization:
QBiotics Group Limited
Class:
INDUSTRY
Study ID:
QB46C-H06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
QBiotics Group Limited
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |